XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balances at Dec. 31, 2022 $ 581,013 $ 128 $ 1,510,518 $ (5,438) $ (924,195)
Beginning Balances (in shares) at Dec. 31, 2022   127,604      
Issuance of common stock upon exercise of stock options, shares   41      
Issuance of common stock upon exercise of stock options 239   239    
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings (5,237)   (5,237)    
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings(share)   746      
Issuance of common stock under Employee Stock Purchase Plan 777   777    
Issuance of common stock under Employee Stock Purchase Plan (in shares)   81      
Stock compensation expense 10,034   10,034    
Total other comprehensive income (Loss) 1,238     1,238  
Net loss (24,332)       (24,332)
Ending Balances at Mar. 31, 2023 563,732 $ 128 1,516,331 (4,200) (948,527)
Ending Balances (in shares) at Mar. 31, 2023   128,472      
Beginning Balances at Dec. 31, 2023 622,072 $ 130 1,554,634 (2,108) (930,584)
Beginning Balances (in shares) at Dec. 31, 2023   129,530      
Issuance of common stock upon exercise of stock options, shares   240      
Issuance of common stock upon exercise of stock options 1,635   1,635    
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings (8,159) $ 1 (8,160)    
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings(share)   995      
Issuance of common stock under Employee Stock Purchase Plan 904   904    
Issuance of common stock under Employee Stock Purchase Plan (in shares)   94      
Stock compensation expense 13,014   13,014    
Total other comprehensive income (Loss) (2,265)     (2,265)  
Net loss (8,721)       (8,721)
Ending Balances at Mar. 31, 2024 $ 618,480 $ 131 $ 1,562,027 $ (4,373) $ (939,305)
Ending Balances (in shares) at Mar. 31, 2024   130,859